Anti-CD3E Recombinant Antibody (Visilizumab) (CAT#: TAB-714)

30 August 2023

Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD3 receptor. Visilizumab is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in [...]

Archived: Tech

0 comments

Anti-SLAMF7 Recombinant Antibody (Elotuzumab) (CAT#: TAB-743)

30 August 2023

Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. Elotuzumab is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma. Immunogen The [...]

Archived: Tech

0 comments

Anti-Human MUC1 Recombinant Antibody (Sontuzumab) (CAT#: TAB-H65)

30 August 2023

Recombinant Humanized (from mouse) antibody to Human MUC1. Host Species Mouse Derivation Humanized (from mouse) Type IgG1 Specificity MUC1 (mucin 1, polymorphic epithelial mucin, PEM, episialin, CD227) [Homo sapiens] Species Reactivity [...]

Archived: Tech

0 comments

Anti-SELL/CD62L Recombinant Antibody (Aselizumab) (CAT#: TAB-720)

30 August 2023

Recombinant humanized (from mouse) antibody expressed in CHO binding to human SELL/CD62L. Aselizumab is an immunosuppressive drug which has been investigated for the use in severely injured patients. [...]

Archived: Tech

0 comments

Anti-Human ITGB2 Recombinant Antibody (Rovelizumab) (CAT#: TAB-044)

30 August 2023

Recombinant monoclonal antibody to CD18. Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. The drug is a monoclonal [...]

Archived: Tech

0 comments

Novel Therapies Based on Small-Molecule Antibodies Hold Immense Promise

30 August 2023

Antibodies, the extraordinary proteins that serve as the frontline troops of the human immune system, have recently gained attention for their ability to combat tiny compounds known as haptens. Because [...]

Archived: Tech

0 comments

Half-Life Strategies in Supporting the Development of Protein Therapeutics

30 August 2023

Therapeutics based on macromolecular proteins and peptides have successfully been efficiently applied to treat serious human diseases. With the development of biotechnologies, a great number of authorized protein therapeutics and [...]

Archived: Tech

0 comments

Efficient Solutions for Researchers in Studying Immune Therapeutics

30 August 2023

Therapeutics that block inhibitory checkpoints or activate stimulatory checkpoints have proven to be effective in restoring anti-tumor immune responses and treating cancer in recent years. In particular, the FDA-approved drugs  [...]

Archived: Tech

0 comments

A high throughput hybridoma generation platform

26 July 2023

a high throughput hybridoma generation platform: Conventional hybridoma preparation uses a polyethylene glycol (PEG)-mediated cell fusion procedure to merge spleen cells with myeloma cell fusion partners to form hybridoma. [...]

Archived: Tech

0 comments

2 Hybrid

26 July 2023

2 hybrid: A key part of gene functional analysis and potential drug target discovery is an understanding of how proteins interact within the cell. The two-hybrid system is a very powerful [...]

Archived: Tech

0 comments

iPSCs therapies for endocrine diseases

26 July 2023

iPSCs therapies for endocrine diseases: he endocrine system is a chemical messenger system, including all glands of the human body and the hormones produced by those glands. In humans, the [...]

Archived: Tech

0 comments

Embryoid Body Formation

26 July 2023

embryoid body formation: Based on the core properties of unlimited self-renewal and differentiation potentiality, human induced pluripotent stem cell (hiPSC) has been served as the exciting cell source for various [...]

Archived: Community

0 comments

Half-Life Strategies in Supporting the Development of Protein Therapeutics

3 July 2023

Therapeutics based on macromolecular proteins and peptides have successfully been efficiently applied to treat serious human diseases. With the development of biotechnologies, a great number of authorized protein therapeutics and [...]

Archived: Tech

0 comments

Promising Strategies for Live Biotherapeutic Products Targeting Obesity

3 July 2023

Obesity is spreading around the world and may contribute to a wide range of harmful conditions, such as cancer, diabetes, fatty liver, and cardiovascular disorders. Obesity can be caused by [...]

Archived: Tech

0 comments

Liposome Drugs Show Potential Therapy Effectiveness

3 July 2023

A novel liposome product, doxorubicin hydrocholoride liposomal injection, has received FDA approval as well as European Commission authorization to be used in the treatment of a variety of cancers, including [...]

Archived: Tech

0 comments

Potential Treatment Strategies for CNS Diseases Require More Research

3 July 2023

For several decades, CNS diseases have caused serious burdens for individuals with these diseases in both physical and mental health. Studies show that more than 95% of CNS diseases have an [...]

Archived: Tech

0 comments